JNJMEGA

Johnson & Johnson

HealthcareDrug Manufacturers - General
$231.29
$0.06(-2.48%)
52W$149.74
$251.71
Updated Jun 23, 02:00 AM
RSI45
RS Rating57/99
Beta-0.03
Volatility17%
F-Score5/9
Mkt Cap$557.4B
EMERGING TREND

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

EMERGING TREND

Johnson & Johnson is attempting to emerge into an uptrend but lacks full moving average alignment. Relative strength is moderate (RS Rating: 57), indicating performance broadly in line with the market. Earnings growth of 91% provides fundamental context to the price action. Volume support will be critical for the stock to resolve this consolidation to the upside.

Relative Strength
57
out of 99
Average
Trend Score
3/4
Minervini Criteria
EMERGING TREND
Risk (Beta)
-0.03
vs S&P 500
LOW VOL
52W Position
80%
from 52W low
Mid Range
Trend & Momentum Analysis

Trend Template (Minervini)

EMERGING TREND3/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$230.17
50 SMA > 100 SMA$235.31
100 SMA > 150 SMA$226.28
150 SMA > 200 SMA$216.00

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$231.70-0.18%BELOW
50 SMA$230.17+0.49%ABOVE
100 SMA$235.31-1.71%BELOW
150 SMA$226.28+2.21%ABOVE
200 SMA$216.00+7.08%ABOVE

Price Performance

1D-2.5%
1W-4.2%
1M-0.2%
3M-3.7%
6M+9.6%
YTD+10.1%
1Y+51.5%
3Y+11.6%
52-Week Trading Range80% from low
$231.29
52W Low$149.74
52W High$251.71

Technical Indicators

RSI (14)NEUTRAL
44.6
305070
Setup ScoreCOOL
3/10
Base depth: 11.8%

Risk Profile

Beta
-0.03
52W Vol
17%
ATR
$5.04
Max DD (1Y)
-11%

Volume Analysis

Today
8.39M
50D Avg
6.74M
Vol Ratio
1.24x
Liquidity
VERY LIQUID

Earnings Momentum

Q4'24-16%
$1.41
Q1'25+239%
$4.54
Q2'25+19%
$2.29
Q3'25+91%
$2.12
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:+1.80%
5 Years:+1.60%
3 Years:+4.10%
TTM:+3.75%

Compounded Profit Growth

10 Years:+0.16%
5 Years:+0.56%
3 Years:-9.49%
TTM:+78.93%

Stock Price CAGR

10 Years:+6.96%
5 Years:+7.11%
3 Years:+11.64%
1 Year:+51.52%

Return on Equity

10Y Avg:24.5%
5Y Avg:29.3%
3Y Avg:30.7%
Last Year:31.7%

Key Metrics

Market Cap$557.4B
Gross Margin69.1%
Net Margin15.8%
Piotroski F-Score5/9

Frequently Asked Questions

Is JNJ in an uptrend right now?

JNJ has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.

Is JNJ overbought or oversold?

JNJ's RSI (14) is 45. The stock is in neutral territory, neither overbought nor oversold.

Is JNJ outperforming the market?

JNJ has a Relative Strength (RS) Rating of 57 out of 99. JNJ is performing about average compared to the market.

Where is JNJ in its 52-week range?

JNJ is trading at $231.29, which is 92% of its 52-week high ($251.71) and 80% above its 52-week low ($149.74).

How volatile is JNJ?

JNJ has a Beta of -0.03 and 52-week volatility of 17%. It's less volatile than the S&P 500 - generally more stable.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.